UCLA Jonsson Comprehensive Cancer Center
Find out how cancer patients can maximize their care
Parton knew he needed extraordinary measures to beat the disease: the cancer was spreading all over his body. That’s when he met with Dr. Edward Garon of the UCLA's Jonsson Comprehensive Cancer Center
Researchers have developed a breakthrough in cancer treatment known as chimeric antigen receptor (CAR) T-cell therapy. This promising form of immunotherapy attacks cancerous cells in the body. In 2017, the U.S. Food and Drug Administration (FDA) approved the first CAR T-cell treatments for patients with specific types of leukemia and lymphoma.
What is CAR T-cell therapy?
March is Women’s History Month, which “honors and celebrates the struggles and achievements of American women throughout the history of the United States.” We take this opportunity to recognize the many contributions women have made to the fabric of our nation, including in the fields of medicine [...]
Medical researchers have had breakthroughs in treating certain types of cancer by bolstering a patient’s immune system. Known as immunotherapy, or biologic therapy, it treats cancer differently than established treatments such as chemotherapy, radiation, bone marrow transplant and surgery.
To date, the U.S. Food and [...]